Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
PrimerDesign Launches World’s Most Affordable qPCR Instrument
Wednesday, August 20, 2014
With a price tag of £3,995 GBP ($6,500 USD) and an ultra-simplified user experience, the instrument, in combination with a new easy-to-use genesig kit range, is designed to make the power of qPCR accessible to a vast swathe of new users.

Improve Gene Expression Results with Bio-Rad’s New Rapid Cell Lysis RT-qPCR Kits
Monday, August 18, 2014
The kits allow researchers to obtain reverse transcription quantitative PCR (RT-qPCR) data directly from cultured cells without the need for a separate RNA purification step.

Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

Analytik Jena Launches New Generation of Thermal Cyclers
Tuesday, August 05, 2014
TAdvanced from Analytik Jena gives excellent heating and cooling rates.

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

Bio-Rad Introduces SsoAdvanced™ Universal Inhibitor-Tolerant SYBR®Green Supermix
Tuesday, July 15, 2014
New reagent delivers quality qPCR data from samples that are challenging to amplify.

QC Labs Selects Bio-Rad’s iQ-Check® Prep Automation Solution for Food Pathogen Detection
Friday, July 11, 2014
Independent food testing laboratory, QC Laboratories has selected Bio-Rad’s iQ-Check Prep Automation Solution for detecting foodborne pathogens.

Bio-Rad Launches New Reagents for Target-Specific Preamplification of Limited Templates for Real-Time PCR
Tuesday, June 10, 2014
Bio-Rad Laboratories, Inc. announced the launch of its SsoAdvanced™ PreAmp Supermix and PrimePCR™ PreAmp Assays.

New 20µl Liquidator 96 from Anachem
Thursday, May 22, 2014
Maximizes users workflow with fast, 96-well pipetting and no complex programming.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 580
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv